Global Non Invasive Colon Cancer Screening
Market Report
2024
Non Invasive Colon Cancer Screening Market Report 2024 (Global Edition)
Non invasive colon cancer screening market size is USD XX million in 2024 and will expand at a compound annual growth rate (CAGR) of 4.70% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Non Invasive Colon Cancer Screening Market Report 2024.
Global Non Invasive Colon Cancer Screening Market Report 2024 Market Size Split by Type (Fecal Immunochemical Test FIT, Guaiac based Fecal Occult Blood Test gFOBT, Stool DNA Test), by Application (Hos...
According to Cognitive Market Research, the global non invasive colon cancer screening market size is USD XX million in 2024 and will expand at a compound annual growth rate (CAGR) of 4.70% from 2024 to 2031.
- North America held the major market of around 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2031.
- Europe accounted for a share of over 30% of the global market size of USD XX million.
- Asia Pacific held the market of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.
- Latin America market of around 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2031.
- Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031.
- The speciality clinics held the highest growth rate in non invasive colon cancer screening market in 2024.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Non Invasive Colon Cancer Screening Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.7% |
| North America Non Invasive Colon Cancer Screening Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 2.9% |
| Europe Non Invasive Colon Cancer Screening Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.2% |
| Asia Pacific Non Invasive Colon Cancer Screening Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.7% |
| South America Non Invasive Colon Cancer Screening Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.1% |
| Middle East and Africa Non Invasive Colon Cancer Screening Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.4% |
| Market Split by Type |
|
| Market Split by Application |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Non Invasive Colon Cancer Screening industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Non Invasive Colon Cancer Screening Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Non Invasive Colon Cancer Screening Market Report Description
Introduction of the Non Invasive Colon Cancer Screening Market
Non-invasive colon cancer screening refers to the utilization of diagnostic techniques that do not require invasive procedures such as colonoscopy or sigmoidoscopy to detect signs of colorectal cancer. These methods typically include stool-based tests like fecal immunochemical tests (FIT), stool DNA tests, and blood tests that detect specific biomarkers associated with colon cancer. Non-invasive screening offers a less discomforting and more accessible alternative to traditional invasive procedures, potentially increasing screening rates and early detection of colorectal cancer. By identifying abnormalities or cancerous cells early on, non-invasive screening methods play a crucial role in improving patient outcomes and reducing mortality rates associated with colorectal cancer.
The rising incidence and prevalence of colorectal cancer globally are driving increased sales in non-invasive colon cancer screening. As colorectal cancer rates continue to climb, healthcare providers are emphasizing the importance of early detection through screening programs. This heightened awareness prompts more individuals to seek out non-invasive screening options like fecal immunochemical tests (FIT) and stool DNA tests, contributing to market growth. With colorectal cancer being one of the most common and deadliest cancers worldwide, the imperative for effective screening methods is clear, propelling sales of non-invasive screening tests to meet the escalating demand for early detection and intervention.
In May 2022, New Horizon Health and Prenetics Group Limited announced a strategic partnership to introduce ColoClear by Circle, the "First Colorectal Cancer Screening Test approved in China", in Hong Kong, marking its first venture abroad in Southeast Asia. The partnership aims to promote ColoClear in Hong Kong, Macau, and Taiwan initially, with potential expansion into Southeast Asian markets.
Key Drivers of Non Invasive Colon Cancer Screening Market
-
Increasing Public Awareness Campaign to Drive Growth in the Market
An increasing public awareness campaign plays a pivotal role in driving growth in the Non-Invasive Colon Cancer Screening Market. As initiatives intensify to educate communities about the importance of early detection and prevention of colorectal cancer, more individuals become proactive in seeking screening services. These campaigns disseminate information about the effectiveness and accessibility of non-invasive screening methods, such as fecal immunochemical tests (FIT) and stool DNA tests, encouraging broader adoption. Moreover, heightened awareness fosters conversations about risk factors, symptoms, and the significance of regular screenings among healthcare providers and patients alike. By destigmatizing discussions around colorectal health and emphasizing the potential for early intervention to save lives, public awareness campaigns create a conducive environment for market expansion, driving increased demand for non-invasive screening solutions and contributing to improved patient outcomes.
-
Supportive Government Initiatives and Policies to Propel the Market
Supportive government initiatives and policies are pivotal in propelling growth within the Non-Invasive Colon Cancer Screening Market. Governments worldwide are recognizing the burden of colorectal cancer and the potential for early detection to mitigate its impact. Consequently, they are implementing programs to subsidize or fully cover the costs of non-invasive screening tests, making them more accessible to the population. Additionally, policymakers are allocating resources towards awareness campaigns, emphasizing the importance of regular screening and promoting preventive healthcare measures. By integrating colorectal cancer screening into national healthcare agendas and guidelines, governments foster a culture of proactive healthcare-seeking behaviour among citizens. Moreover, regulatory frameworks ensure the quality and safety of screening tests, instilling confidence in healthcare providers and patients. Overall, supportive government initiatives create an enabling environment for market growth, driving increased adoption of non-invasive screening methods and ultimately reducing the burden of colorectal cancer.
Restraint Factors Of Non Invasive Colon Cancer Screening Market
-
High Costs Associated with Non-invasive Screening Tests to Pose a Barrier
The high costs associated with non-invasive screening tests present a significant barrier to widespread adoption. While these tests offer benefits such as convenience and reduced discomfort compared to invasive procedures, their affordability remains a concern for many individuals, particularly those without adequate insurance coverage. The expenses associated with purchasing testing kits or undergoing diagnostic procedures can deter individuals from seeking screening, especially in regions with limited financial resources or where healthcare costs are high. As a result, efforts to reduce the cost of non-invasive screening tests through subsidies, insurance coverage expansions, or the development of more cost-effective testing solutions are crucial to overcoming this barrier and ensuring equitable access to colorectal cancer screening for all populations.
-
Impact of Covid-19 on the Non Invasive Colon Cancer Screening Market
The COVID-19 pandemic has had a profound negative impact on the Non-Invasive Colon Cancer Screening Market. Lockdown measures, overwhelmed healthcare systems, and redirected resources have disrupted routine screening programs, leading to a decline in screening rates. Patients have deferred non-urgent medical appointments due to fears of exposure to the virus in healthcare settings, further reducing screening uptake. Additionally, healthcare facilities have prioritized COVID-19 testing and treatment, diverting attention and resources away from colorectal cancer screening initiatives. Delays in screenings have resulted in missed opportunities for early detection and intervention, potentially leading to an increase in advanced-stage diagnoses and poorer patient outcomes. The economic downturn resulting from the pandemic has also exacerbated affordability issues, making it even more challenging for individuals to access screening services. Overall, the COVID-19 pandemic has significantly hindered progress in colorectal cancer screening efforts, underscoring the urgent need for targeted interventions to mitigate its impact.
We have various report editions of Non Invasive Colon Cancer Screening Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Landscape of the Non Invasive Colon Cancer Screening Market
The competitive landscape of the Non-Invasive Colon Cancer Screening Market is characterized by intense rivalry among players striving to innovate and expand their product portfolios. Key strategies include technological advancements, strategic partnerships, and market expansion efforts to gain a competitive edge in this dynamic and rapidly evolving market segment.
Non Invasive Colon Cancer Screening Industry News
In March 2021, Olympus disclosed that the FDA had granted 510(k) clearance to Narrow Band Imaging for evaluating the neoplastic potential of colorectal polyps. Utilizing the NBI International Colorectal Endoscopic (NICE) classification during screening colonoscopies enables physicians to confidently predict the histology of diminutive polyps (5mm or smaller). Implementation of NBI serves as a valuable decision-making support tool, offering benefits to patients and healthcare systems alike by facilitating informed medical assessments during colorectal examinations.(Source:https://medical.olympusamerica.com/articles/fda-clears-olympus%E2%80%99-narrow-band-imaging%C2%AE-nbi-use-assessing-colonic-lesions)
Top Companies Market Share in Non Invasive Colon Cancer Screening Industry: (In no particular order of Rank)
- NOVIGENIX SA
- EIKEN CHEMICAL CO. LTD.
- New Horizon
- Clinical Genomics Technologies Pty Ltd.
- Exact Sciences Corporation
- Epigenomics AG
- bioMérieux Inc.
- Olympus Corporation
- KARL STORZ SE & Co. KG
- FUJIFILM Holdings America Corporation
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Regional Analysis of Non Invasive Colon Cancer Screening Market
Which Region Dominates the Non Invasive Colon Cancer Screening Market in 2024?
According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue due to factors such as high healthcare expenditure, well-established healthcare infrastructure, and favourable reimbursement policies. Additionally, rising awareness campaigns and government initiatives promoting colorectal cancer screening drive demand. Moreover, a large population base, coupled with a growing geriatric population prone to colorectal cancer, further boosts market growth. Advanced technological developments and increasing adoption of non-invasive screening methods also contribute to market dominance in North America.
Which Region is Expanding at the Fastest CAGR?
The Asia-Pacific is the fastest growing region attributed to several factors. Rapid urbanization and industrialization lead to lifestyle changes associated with an increased risk of colorectal cancer, driving demand for screening. Moreover, improving healthcare infrastructure and rising disposable incomes enhance accessibility to screening services. Government initiatives aimed at promoting cancer awareness and early detection also play a significant role. Furthermore, a growing elderly population and expanding healthcare expenditure contribute to the region's rapid market growth.
The current report Scope analyzes Non Invasive Colon Cancer Screening Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Non Invasive Colon Cancer Screening Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
North America Non Invasive Colon Cancer Screening Market
According to Cognitive Market Research, the global non invasive colon cancer screening market size was estimated at USD XX Million out of which North America held the major market of around 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2031. Sales of non-invasive colon cancer screening are poised to rise in North America due to factors such as increasing adoption of preventive healthcare practices, growing awareness about the benefits of early detection, and favourable reimbursement policies. Additionally, collaborations between healthcare providers and government agencies enhance accessibility to screening services, driving increased demand. In North America, the fecal immunochemical test (FIT) segment is expected to see significant growth, fuelled by its accuracy and ease of use, thereby further solidifying its market dominance in the region.
- According to Cognitive Market Research, The United States non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.7% during the forecast period. Sales of non-invasive colon cancer screening in the U.S. are expected to rise due to increasing awareness campaigns, favourable reimbursement policies, and a growing emphasis on preventive healthcare practices.
- Canada non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.7% during the forecast period. In Canada, sales of non-invasive colon cancer screening are poised to increase as a result of expanding healthcare infrastructure, rising public awareness about colorectal cancer, and government-supported screening programs.
- Mexico non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.4% during the forecast period.
Europe Non Invasive Colon Cancer Screening Market
According to Cognitive Market Research, with a market value of USD XX million in 2024 and projected to expand at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031. Europe accounted for a share of around 30% of the global market size of USD XX million. In Europe, sales of non-invasive colon cancer screening are expected to increase due to the region's aging population, leading to a higher incidence of colorectal cancer. Additionally, government initiatives promoting cancer awareness and screening programs drive demand for non-invasive screening methods. Furthermore, advancements in technology and diagnostic tools enhance the accuracy and efficiency of screening tests, contributing to market growth. The stool DNA test segment is projected to witness substantial growth in Europe, driven by its superior sensitivity in detecting colorectal cancer biomarkers, making it a preferred choice for patients and healthcare providers alike.
- The United Kingdom non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. Sales of non-invasive colon cancer screening in the UK are anticipated to grow due to the implementation of national screening programs, technological advancements, and efforts to reduce healthcare disparities among underserved populations.
- France non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.4% during the forecast period.
- Germany non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.4% during the forecast period. In Germany, sales of non-invasive colon cancer screening are expected to rise owing to increasing healthcare expenditure, a well-developed healthcare system, and rising public awareness about the benefits of early detection and prevention.
- Italy non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.6% during the forecast period.
- Russia non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.2% during the forecast period.
- Spain non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.3% during the forecast period.
- Luxembourg non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.3% during the forecast period.
- Portugal non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period.
- Greece non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period.
- Rest of Europe non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 1.9% during the forecast period.
Asia Pacific Non Invasive Colon Cancer Screening Market
According to Cognitive Market Research, the global non invasive colon cancer screening market size was estimated at USD XX Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031. Sales of non-invasive colon cancer screening in Asia Pacific are anticipated to grow rapidly due to factors such as increasing healthcare expenditure, rising awareness about cancer prevention, and improving healthcare infrastructure. Additionally, technological innovations in screening technologies and the availability of affordable screening options further drive market growth. In Asia Pacific, the fecal immunochemical test (FIT) segment is expected to dominate, owing to its widespread adoption and proven efficacy in detecting colorectal cancer, thus cementing its position as the leading screening method in the region.
- According to Cognitive Market Research, China non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 6.2% during the forecast period. Sales of non-invasive colon cancer screening in China are poised to increase due to improving access to healthcare services, rising disposable incomes, and government initiatives promoting cancer awareness and early detection programs.
- Japan non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 5.2% during the forecast period.
- India non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. In India, sales of non-invasive colon cancer screening are anticipated to grow rapidly due to increasing healthcare infrastructure, rising cancer incidence rates, and growing awareness about preventive healthcare measures among the population.
- South Korea non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period.
- Australia non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 6.4% during the forecast period.
- South East Asia non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 7.7% during the forecast period.
- Rest of Asia Pacific non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period.
South America Non Invasive Colon Cancer Screening Market
According to Cognitive Market Research, the global non invasive colon cancer screening market size was estimated at USD XX Million out of which Latin America market of around 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2031. In Latin America, sales of non-invasive colon cancer screening are poised to increase due to improving access to healthcare services, rising disposable incomes, and growing awareness about the importance of preventive healthcare measures. Additionally, government initiatives promoting cancer screening programs and partnerships between healthcare organizations and non-profit organizations drive demand for screening services. Furthermore, advancements in screening technologies and the availability of affordable screening options contribute to market growth. In Latin America, the stool DNA test segment is expected to witness significant growth, offering a highly accurate and convenient screening option for patients across the region.
- According to Cognitive Market Research, Brazil non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.7% during the forecast period. Sales of non-invasive colon cancer screening in Brazil are expected to rise owing to expanding healthcare access, government initiatives promoting cancer screening, and increasing public awareness about the importance of early detection and prevention.
- Argentina non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. In Argentina, sales of non-invasive colon cancer screening are poised to increase due to improving healthcare infrastructure, rising disposable incomes, and government-supported screening programs aimed at reducing cancer mortality rates.
- Colombia non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.9% during the forecast period.
- Peru non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.3% during the forecast period.
- Chile non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.4% during the forecast period.
- Rest of Latin America non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period.
Middle East and Africa Non Invasive Colon Cancer Screening Market
According to Cognitive Market Research, the global Non invasive colon cancer screening market size was estimated at USD XX Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031. Sales of non-invasive colon cancer screening in the Middle East and Africa (MEA) region are expected to increase due to factors such as rising healthcare expenditure, improving healthcare infrastructure, and increasing awareness about colorectal cancer screening. Additionally, partnerships between government agencies and international organizations drive the implementation of screening programs, enhancing accessibility to screening services. Furthermore, advancements in technology and the availability of cost-effective screening options contribute to market growth. In MEA, the fecal immunochemical test (FIT) segment is projected to lead, offering a widely adopted and effective screening method for detecting colorectal cancer in the region.
- According to Cognitive Market Research, GCC Countries non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 5.2% during the forecast period. Sales of non-invasive colon cancer screening in GCC countries are anticipated to grow due to increasing healthcare investments, rising prevalence of lifestyle-related diseases, and efforts to promote preventive healthcare measures among the population.
- Egypt non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.7% during the forecast period.
- South Africa non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 5.4% during the forecast period. In South Africa, sales of non-invasive colon cancer screening are expected to rise owing to improving healthcare access, increasing awareness about colorectal cancer, and government initiatives aimed at reducing cancer mortality rates through early detection programs.
- Turkey non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.9% during the forecast period.
- Nigeria non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period.
- Rest of MEA non-invasive colon cancer screening market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.4% during the forecast period.
Non Invasive Colon Cancer Screening Market Analysis
Global Non Invasive Colon Cancer Screening Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Non Invasive Colon Cancer Screening Industry growth. Non Invasive Colon Cancer Screening market has been segmented with the help of its Type, Application , and others. Non Invasive Colon Cancer Screening market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Non Invasive Colon Cancer ScreeningType Segment Analysis
According to Cognitive Market Research, fecal immunochemical test fit held the major market share over the forecast period due to its high accuracy, ease of use, and non-invasive nature, making it a preferred choice for colorectal cancer screening. Additionally, growing awareness campaigns promoting regular screenings and the simplicity of FIT procedures contribute to its market dominance. Moreover, advancements in FIT technology, such as improved sensitivity and specificity, further drive its adoption and market share expansion.
Stool DNA test is the fastest-growing category over the forecast period, driven by several factors, including their superior sensitivity in detecting colorectal cancer biomarkers, leading to increased adoption among healthcare providers and patients. Additionally, technological advancements enhancing the accuracy and reliability of stool DNA tests contribute to their rapid market growth. Furthermore, growing patient preference for non-invasive screening methods and expanding availability of stool DNA testing kits further propel sales in this segment.
- Fecal Immunochemical Test FIT
- Guaiac based Fecal Occult Blood Test gFOBT
- Stool DNA Test
Non Invasive Colon Cancer Screening Market Share (%) by Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Non Invasive Colon Cancer Screening Industry. Request a Free Sample PDF!
Non Invasive Colon Cancer Screening?????? Segment Analysis
According to Cognitive Market Research, hospitals hold a prominent market share due to their role as primary healthcare providers, where a significant portion of colorectal cancer screenings are conducted. Moreover, hospitals offer comprehensive services, including both invasive and non-invasive screening methods, catering to diverse patient populations. Additionally, the ability of hospitals to provide follow-up care and treatment further solidifies their position in the market, driving continued sales growth and market dominance.
Speciality clinics is the fastest-growing category over the forecast period, attributed to several factors, including their focus on cancer screening and prevention, leading to increased patient referrals and demand. Specialty clinics often offer streamlined services, specialized expertise, and personalized care, appealing to individuals seeking dedicated colorectal cancer screening services. Moreover, the convenience, accessibility, and efficiency of specialty clinics contribute to their attractiveness, driving market expansion and making them the fastest-growing category in the forecast period.
- Hospitals
- Speciality Clinics
- Ambulatory Surgical Centers
- Home Care Setting
Non Invasive Colon Cancer Screening Market Share (%) by Application in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
- Author's Say's, The global non invasive colon cancer screening market will expand significantly by 4.70% CAGR between 2024 to 2031.
- The sales of Fecal Immunochemical Test (FIT) are poised to rise due to its high accuracy, non-invasiveness, ease of use, and increasing awareness campaigns promoting colorectal cancer screening and early detection.
- Hospital sales are anticipated to surge owing to growing demand for comprehensive healthcare services, advancements in medical technology, increasing prevalence of chronic diseases, and expanding healthcare infrastructure.
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Non Invasive Colon Cancer Screening Market
Sources from Medical Devices & Consumables Industry
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Non Invasive Colon Cancer Screening Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Type | Fecal Immunochemical Test FIT, Guaiac based Fecal Occult Blood Test gFOBT, Stool DNA Test |
| Application | Hospitals, Speciality Clinics, Ambulatory Surgical Centers, Home Care Setting |
| List of Competitors | NOVIGENIX SA, EIKEN CHEMICAL CO. LTD., New Horizon, Clinical Genomics Technologies Pty Ltd., Exact Sciences Corporation, Epigenomics AG, bioMérieux Inc., Olympus Corporation, KARL STORZ SE & Co. KG, FUJIFILM Holdings America Corporation |
This chapter will help you gain GLOBAL Market Analysis of Non Invasive Colon Cancer Screening. Further deep in this chapter, you will be able to review Global Non Invasive Colon Cancer Screening Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Non Invasive Colon Cancer Screening Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Non Invasive Colon Cancer Screening Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Non Invasive Colon Cancer Screening Revenue Market Size By Region
-
-
1.3 Global Non Invasive Colon Cancer Screening Market Size By Type 2019 -2031
-
1.3.1 Fecal Immunochemical Test FIT Market Size
-
1.3.2 Guaiac based Fecal Occult Blood Test gFOBT Market Size
-
1.3.3 Stool DNA Test Market Size
-
-
1.4 Global Non Invasive Colon Cancer Screening Market Size By Application 2019 -2031
-
1.4.1 Hospitals Market Size
-
1.4.2 Speciality Clinics Market Size
-
1.4.3 Ambulatory Surgical Centers Market Size
-
1.4.4 Home Care Setting Market Size
-
-
1.5 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.6 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.6.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.6.2 Global Market Revenue Split By Type
-
1.6.3 Global Market Revenue Split By Application
-
1.6.4 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Non Invasive Colon Cancer Screening Market Size 2019 - 2031
-
2.1.1 North America Non Invasive Colon Cancer Screening Market Size By Country 2019 - 2031
-
2.1.2 North America Non Invasive Colon Cancer Screening Market Size by Type 2019 -2031
-
2.1.2.1 North America Fecal Immunochemical Test FIT Market Size
-
2.1.2.2 North America Guaiac based Fecal Occult Blood Test gFOBT Market Size
-
2.1.2.3 North America Stool DNA Test Market Size
-
-
2.1.3 North America Non Invasive Colon Cancer Screening Market Size by Application 2019 -2031
-
2.1.3.1 North America Hospitals Market Size
-
2.1.3.2 North America Speciality Clinics Market Size
-
2.1.3.3 North America Ambulatory Surgical Centers Market Size
-
2.1.3.4 North America Home Care Setting Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Non Invasive Colon Cancer Screening Market Size 2019 - 2031
-
3.1.1 Europe Non Invasive Colon Cancer Screening Market Size By Country 2019 - 2031
-
3.1.2 Europe Non Invasive Colon Cancer Screening Market Size by Type 2019 -2031
-
3.1.2.1 Europe Fecal Immunochemical Test FIT Market Size
-
3.1.2.2 Europe Guaiac based Fecal Occult Blood Test gFOBT Market Size
-
3.1.2.3 Europe Stool DNA Test Market Size
-
-
3.1.3 Europe Non Invasive Colon Cancer Screening Market Size by Application 2019 -2031
-
3.1.3.1 Europe Hospitals Market Size
-
3.1.3.2 Europe Speciality Clinics Market Size
-
3.1.3.3 Europe Ambulatory Surgical Centers Market Size
-
3.1.3.4 Europe Home Care Setting Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Non Invasive Colon Cancer Screening Market Size 2019 - 2031
-
4.1.1 Asia Pacific Non Invasive Colon Cancer Screening Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Non Invasive Colon Cancer Screening Market Size by Type 2019 -2031
-
4.1.2.1 Asia Pacific Fecal Immunochemical Test FIT Market Size
-
4.1.2.2 Asia Pacific Guaiac based Fecal Occult Blood Test gFOBT Market Size
-
4.1.2.3 Asia Pacific Stool DNA Test Market Size
-
-
4.1.3 Asia Pacific Non Invasive Colon Cancer Screening Market Size by Application 2019 -2031
-
4.1.3.1 Asia Pacific Hospitals Market Size
-
4.1.3.2 Asia Pacific Speciality Clinics Market Size
-
4.1.3.3 Asia Pacific Ambulatory Surgical Centers Market Size
-
4.1.3.4 Asia Pacific Home Care Setting Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America Non Invasive Colon Cancer Screening Market Size 2019 - 2031
-
5.1.1 South America Non Invasive Colon Cancer Screening Market Size By Country 2019 - 2031
-
5.1.2 South America Non Invasive Colon Cancer Screening Market Size by Type 2019 -2031
-
5.1.2.1 South America Fecal Immunochemical Test FIT Market Size
-
5.1.2.2 South America Guaiac based Fecal Occult Blood Test gFOBT Market Size
-
5.1.2.3 South America Stool DNA Test Market Size
-
-
5.1.3 South America Non Invasive Colon Cancer Screening Market Size by Application 2019 -2031
-
5.1.3.1 South America Hospitals Market Size
-
5.1.3.2 South America Speciality Clinics Market Size
-
5.1.3.3 South America Ambulatory Surgical Centers Market Size
-
5.1.3.4 South America Home Care Setting Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Non Invasive Colon Cancer Screening Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Non Invasive Colon Cancer Screening Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Non Invasive Colon Cancer Screening Market Size by Type 2019 -2031
-
6.1.2.1 Middle East and Africa Fecal Immunochemical Test FIT Market Size
-
6.1.2.2 Middle East and Africa Guaiac based Fecal Occult Blood Test gFOBT Market Size
-
6.1.2.3 Middle East and Africa Stool DNA Test Market Size
-
-
6.1.3 Middle East and Africa Non Invasive Colon Cancer Screening Market Size by Application 2019 -2031
-
6.1.3.1 middle_east_and_africa_title} Hospitals Market Size
-
6.1.3.2 middle_east_and_africa_title} Speciality Clinics Market Size
-
6.1.3.3 middle_east_and_africa_title} Ambulatory Surgical Centers Market Size
-
6.1.3.4 middle_east_and_africa_title} Home Care Setting Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Non Invasive Colon Cancer Screening Market Size by Type 2019 -2031
-
7.1.2 Country 1Non Invasive Colon Cancer Screening Market Size by Application 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Non Invasive Colon Cancer Screening Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 NOVIGENIX SA
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 EIKEN CHEMICAL CO. LTD.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 New Horizon
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Clinical Genomics Technologies Pty Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Exact Sciences Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Epigenomics AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 bioMérieux Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Olympus Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 KARL STORZ SE & Co. KG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 FUJIFILM Holdings America Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2019 -2031
-
10.1 Fecal Immunochemical Test FIT
-
10.1.1 Global Non Invasive Colon Cancer Screening Revenue Market Size and Share by Fecal Immunochemical Test FIT 2019 -2031
-
-
10.2 Guaiac based Fecal Occult Blood Test gFOBT
-
10.2.1 Global Non Invasive Colon Cancer Screening Revenue Market Size and Share by Guaiac based Fecal Occult Blood Test gFOBT 2019 -2031
-
-
10.3 Stool DNA Test
-
10.3.1 Global Non Invasive Colon Cancer Screening Revenue Market Size and Share by Stool DNA Test 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
-
11.1 Hospitals
-
11.1.1 Global Non Invasive Colon Cancer Screening Revenue Market Size and Share by Hospitals 2019 - 2031
-
-
11.2 Speciality Clinics
-
11.2.1 Global Non Invasive Colon Cancer Screening Revenue Market Size and Share by Speciality Clinics 2019 - 2031
-
-
11.3 Ambulatory Surgical Centers
-
11.3.1 Global Non Invasive Colon Cancer Screening Revenue Market Size and Share by Ambulatory Surgical Centers 2019 - 2031
-
-
11.4 Home Care Setting
-
11.4.1 Global Non Invasive Colon Cancer Screening Revenue Market Size and Share by Home Care Setting 2019 - 2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Non Invasive Colon Cancer Screening market
Chapter 12 Research Findings
-
12.1 Key Takeaways
-
12.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
12.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Non Invasive Colon Cancer Screening Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Non Invasive Colon Cancer Screening Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Non Invasive Colon Cancer Screening Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Non Invasive Colon Cancer Screening Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Non Invasive Colon Cancer Screening Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Non Invasive Colon Cancer Screening Market
Key Questions Answered By Non Invasive Colon Cancer Screening Market Report 2024
| Why Fecal Immunochemical Test FIT have a significant impact on Non Invasive Colon Cancer Screening market? |
| What are the key factors affecting the Fecal Immunochemical Test FIT and Guaiac based Fecal Occult Blood Test gFOBT of Non Invasive Colon Cancer Screening Market? |
| What is the CAGR/Growth Rate of Hospitals during the forecast period? |
| By type, which segment accounted for largest share of the global Non Invasive Colon Cancer Screening Market? |
| Which region is expected to dominate the global Non Invasive Colon Cancer Screening Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
